跳转至内容
Merck
CN
  • Novel PNKP mutations causing defective DNA strand break repair and PARP1 hyperactivity in MCSZ.

Novel PNKP mutations causing defective DNA strand break repair and PARP1 hyperactivity in MCSZ.

Neurology. Genetics (2019-05-02)
Ilona Kalasova, Hana Hanzlikova, Neerja Gupta, Yun Li, Janine Altmüller, John J Reynolds, Grant S Stewart, Bernd Wollnik, Gökhan Yigit, Keith W Caldecott
摘要

To address the relationship between novel mutations in polynucleotide 5'-kinase 3'-phosphatase (PNKP), DNA strand break repair, and neurologic disease. We have employed whole-exome sequencing, Sanger sequencing, and molecular/cellular biology. We describe here a patient with microcephaly with early onset seizures (MCSZ) from the Indian sub-continent harboring 2 novel mutations in PNKP, including a pathogenic mutation in the fork-head associated domain. In addition, we confirm that MCSZ is associated with hyperactivation of the single-strand break sensor protein protein poly (ADP-ribose) polymerase 1 (PARP1) following the induction of abortive topoisomerase I activity, a source of DNA strand breakage associated previously with neurologic disease. These data expand the spectrum of PNKP mutations associated with MCSZ and show that PARP1 hyperactivation at unrepaired topoisomerase-induced DNA breaks is a molecular feature of this disease.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
抗-泛腺苷二磷酸核糖结合试剂, from Escherichia coli
Sigma-Aldrich
p53(Ab-3)(突变型)小鼠单克隆抗体(PAb240), liquid, clone PAb240, Calbiochem®